Environmental, Social, and Governance
Patient First, Medicine for Good
Continuously enhancing the company's overall ESG performance
People-Oriented
Health Accessibility
National Centralized Procurement
All 6 products in the line won the bid, with the agreed procurement volume increasing from 35.34 million units in the initial round to 46.86 million units in the subsequent rounds, a growth rate of 32.6%, benefiting more patients with high quality and affordable prices;
Inclusive Product Technology
Gan & Lee Pharmaceuticals has built a diversified international market expansion model, adopting a cooperation model of "intellectual property licensing + technology sharing + industrial ecosystem co-construction" to continuously promote the global accessibility of insulin products. Currently, our business covers 21 emerging markets in Eurasia, Asia-Pacific, Latin America, and Africa, gradually providing more patients with diabetes mellitus with high-quality, affordable, full-category third-generation insulin products.
Fair Pricing
The company implements flexible and precise pricing strategies based on the economic levels, medical systems, and patient payment capabilities of different regions, ensuring that supply prices match the actual local market conditions. This fair and reasonable pricing strategy promotes high-quality insulin products to benefit a wider range of patients globally.
Talent Development
At Gan & Lee Pharmaceuticals, "building a great company" is not only embedded in our organizational culture, but also guides the fulfillment of responsibility in the human resources system.
We firmly believe that the essence of a company's sustainable development lies in the sustainable development of its people. We always adhere to "Science and Excellence" as our core and integrate the ESG concept throughout the entire chain of talent management.
Diverse and Inclusive Equal Development Opportunities
Strictly complying with laws and regulations such as the "Labor Law of the People's Republic of China", the "Law of the People's Republic of China on Promotion of Employment", the "Law of the People's Republic of China on the Protection of Rights and Interests of Women", and the "Regulations on the Employment of Persons with Disabilities", we adhere to the principle of fairness and impartiality in employment and are committed to building an equal, diverse, and inclusive workplace. Recruitment is solely based on job requirements and individual abilities. Any form of discrimination based on age, gender, education, nationality, ethnicity, marital status, or other factors is strictly prohibited.
Diversified Job Rank and Grade System
Focusing on the four major business segments of R&D, production and operations, functional departments, and marketing, we have established a job rank and grade system covering three sequences and 25 levels. We have also specifically designed a "dual-channel" career development path for R&D talent. This system clarifies the corresponding ability, performance, and management experience requirements for each sequence and level, systematically drives talent development, motivates core personnel, and ensures fair and efficient development opportunities and compensation.
Talent Development System
Guided by the overarching principles of "corporate strategy, talent strategy, and corporate culture", we have built an integrated talent development framework of "training system + training mechanisms + development process + digital platform", so as to provide clear and sustainable path support for employee growth and organizational capability enhancement.
Occupational Health
Based on the construction of a systematic management system, with proactive risk prevention as the key, supported by a safety culture, and guaranteed by closed-loop accident management and strict supervision, Gan & Lee Pharmaceuticals continuously strives to create a "zero-harm, healthy, and safe" working environment.
Social Contribution
Since launching the national public welfare initiative in 2020, Gan & Lee Pharmaceuticals has visited 7 provinces, including Hubei, Inner Mongolia, Tibet, Sichuan, and Qinghai, continuously fulfilling its public welfare commitment to "Passing on Care, Sowing Hope". In September 2025, upon learning that Zhongdong Primary School in Piaojing Town, Bijie City, Guizhou Province, was facing a shortage of supplies due to a sudden flood, the company quickly activated the emergency response mechanism, launched the "Warmth for Zhongdong" special public welfare donation event, and promptly provided urgently needed material support to the affected school.
Passing on Care, Sowing Hope
Gathering Lasting Strength from Small Acts of Kindness
Deepening our Commitment to Public Welfare Initiatives for Chronic Disease Management